In a subset of patients the hormone leptin can be leveraged as a therapeutic agent to move fat out of the liver.

Noninvasive tests haven’t replaced liver biopsies, but they have sharply reduced the need for them. Two Michigan Medicine experts examine the debate in a new paper.

Doctors are ordering too many liver-related blood tests at the same time, new research shows, which may lead to unneeded worry, biopsies and costs.